Two Sigma Advisers
BRTX icon

Two Sigma Advisers’s BioRestorative Therapies BRTX Stock Holding History

Two Sigma Advisers’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,700
Closed -$34.3K – 2468
2023
Q4 		$34.3K Sell
19,700
-4,900
-20% -$9.35K ﹤0.01% 2422
2023
Q3 		$44K Sell
24,600
-1,700
-6% -$4.29K ﹤0.01% 2288
2023
Q2 		$116K Sell
26,300
-2,800
-10% -$13.4K ﹤0.01% 2192
2023
Q1 		$98.9K Buy
+29,100
New +$89.3K ﹤0.01% 2387

Other funds holding BRTX

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Two Sigma Advisers's BRTX Position: Q1 2024 in Review

Two Sigma Advisers sold out of BioRestorative Therapies (BRTX) in Q1 2024, closing a stake of 19,700 shares — an estimated $34.3K sold.

Two Sigma Advisers first reported a position in BRTX in Q1 2023 and held it in 4 quarters. The position peaked at $116K in Q2 2023. 12 funds tracked by Wall St. Rank hold BRTX as of Q1 2024.

  • Two Sigma Advisers reported no remaining BioRestorative Therapies position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 19,700 BioRestorative Therapies shares in Q1 2024, an estimated $34.3K.
  • Two Sigma Advisers first reported a position in BioRestorative Therapies in Q1 2023 and held it in 4 quarters.
  • Two Sigma Advisers's BioRestorative Therapies position peaked at $116K in Q2 2023.
  • 12 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q1 2024.

Based on Two Sigma Advisers's 13F filing for Q1 2024, filed 15 May 2024.